Glenmark Pharmaceuticals Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 2,773.40 | 2,454.45 | 2,468.99 |
| Operating Expense | 1,821.74 | 2,483.80 | 2,041.30 |
| Net Profit | 735.64 | -73.90 | 282.07 |
| Net Profit Margin | 26.52% | -3.01% | 11.42% |
| Earning Per Share | 26.07 | -2.62 | 10 |
| EBIDTA | 934.05 | 4.14 | 363.23 |
| Effective Tax Rate | 11.86% | -0% | 0% |
Particulars
Jun 2026
Revenue2,773.40
Operating Expense1,821.74
Net Profit735.64
Net Profit Margin26.52
Earning Per Share26.07
EBIDTA934.05
Effective Tax Rate11.86
